Evotec SE (EVO) EBT (2009 - 2025)

Evotec SE (EVO) has 9 years of EBT data on file, last reported at -$100.9 million in Q4 2025.

• For the quarter ending Q4 2025, EBT rose 51.3% year-over-year to -$100.9 million; the trailing twelve-month figure through Dec 2025 stood at -$308.1 million (down 4.87% YoY), and the FY2025 full-year result was -$101.0 million, up 51.27% from the prior year.
• EBT fell to -$100.9 million in Q4 2025, from -$50222.6 in the prior quarter.
• In the past five years, EBT ranged from a high of $270.8 million in Q4 2021 to a low of -$207.1 million in Q4 2024.
• A 5-year average of -$18.7 million and a median of -$25967.9 in 2022 frame the typical range for EBT.
• Across the five-year window, EBT surged 1784.32% in 2021 and plunged 258.07% in 2024, its largest moves.
• Tracing EVO's EBT over 5 years: stood at $270.8 million in 2021, then slumped by 158.05% to -$157.2 million in 2022, then surged by 44.88% to -$86.7 million in 2023, then tumbled by 138.99% to -$207.1 million in 2024, then jumped by 51.3% to -$100.9 million in 2025.
• Business Quant data shows EVO's EBT at -$100.9 million in Q4 2025, -$50222.6 in Q3 2025, and -$207.1 million in Q4 2024.